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Review

Environmental chemicals targeting thyroid
Thomas R. Zoeller
Biology Department and Program in Molecular and Cellular Biology, University of Massachusetts, Amherst, U.S.A.

Abstract
Thyroid hormones (THs) are required for normal brain and somatic development and for the
proper regulation of physiology in both children and adults. Thyroid function is controlled by
the dynamic interrelationships between the hypothalamus, the pituitary and the thyroid. These
dynamic relationships maintain circulating levels of THs within a narrow range under normal
conditions. Normally, there is likely to be a tight relationship between changes in circulating
levels of THs and changes in TH action in various target tissues. This relationship is maintained by tissue-level mechanisms that include TH metabolism and transport. Environmental
chemicals that interfere with TH signaling mechanisms (Endocrine Disrupting Chemicals,
EDCs) may produce adverse effects both in the individual and in a population. Because of the
complex nature of the regulation of thyroid function and TH action, the consequences of EDC
exposure is also likely to be complex and our ability to understand these effects as well as to
screen for potential EDCs must consider this complexity. Specifically, if there are chemicals in
the environment that directly interfere with TH action through their receptors but do not affect
circulating TH levels, they would not be identified as thyroid toxicants by currently applied
screening methods or by epidemiological studies. The goal of this review is therefore to identify
the issues that must be clearly resolved before effective risk assessment can be performed.
Key words: Thyroid hormones, Endocrine disruptors, Environmental chemicals, Thyroid toxicants

The Hypothalamic Pituitary Thyroid
Axis (HPT) Axis
To develop efficient risk assessment strategies
for thyroid toxicants, it is important to understand
both the normal functioning of the hypothalamic-pi-
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tuitary-thyroid axis (HPT) and what we know about
individual thyroid toxicants. To this end, background
information about the HPT axis and its relevance to
thyroid toxicology is reviewed here.
Circulating levels of Thyroid Hormones (THs) are
maintained within a relatively narrow range1 in large
part by a negative feedback relationship between circulating levels of THs and those of Thyroid Stimulating Hormone (TSH). THs appear to exert this effect
by acting on one subtype of the TH receptor (TR).
TRs are encoded by two separate genes,  and , the
primary transcripts of which are alternatively spliced
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to generate three major products capable of mediating the response to TH; these transcripts – TR1,
TR1, and TR2 – exhibit a very selective spatial
and temporal pattern of expression in the developing
and adult brain.2-4 Interestingly, TR2 is expressed
in the pituitary gland5 and in the hypothalamic Paraventricular Nucleus (PVN),6 and appears to be the
predominant mediator of the negative feedback action
of TH on TSH.7 Thus, if the TR2 isoform is solely or
predominantly responsible for the negative feedback
actions of TH on the hypothalamus and pituitary, then
environmental chemicals that interact with TRs will
affect this negative feedback system if, and only if,
they interact with the TR2 isoform.
Finally, although circulating levels of thyroid hormones are generally maintained within a narrow range,
the range is far narrower for an individual than for
the population,1,8 and individual genetics is a major
contributor defining the set-point around which the
HPT axis is regulated.9 The variability in measures
of thyroid hormones should be considered both in
calculating the power of studies designed to identify
associations between environmental exposures and
TH signaling8 and in interpreting the findings.
The principal pathway of TH clearance from serum is by conjugation to glucuronic acid or sulfate.10
The Constitutive Androstane Receptor (CAR) and
the Pregnane X Receptor (PXR) play central roles
in the xenobiotic-induced clearance of T3 and T4 and
the subsequent ability of environmental chemicals to
reduce serum concentrations of these hormones.11
Both CAR and PXR are nuclear (orphan) receptors
that respond to classes of xenobiotic chemicals and
induce the expression of phase I-III enzymes involved
in the detoxification and elimination of steroids,
bile acids and xenobiotics.12-14 Phase I enzymes (the
cytochrome P450) largely hydroxylate hydrophobic
chemicals (including xenobiotic chemicals and steroid
hormones), which can then be further modified by
phase II enzymes such as Glucuronyl Transferases
(UDPGTs), Glutathione-S-Transferases (GSTs), and
Sulfo Transferases (SULTs). These chemical metabolites are then transported across plasma membranes
for elimination by phase III transporters such as the
Multidrug Resistance-associated Protein 2 (MRP2)
and the Multidrug Resistance Protein 1 (MRP1).
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Mechanisms of interactions of HPT
with Xenobiotics
Serum half-life of thyroxin (T4) is also controlled
in part by serum binding proteins. Two important elements of serum T4 in humans are its half-life of 7-10
days and its serum concentration of 100 nM.15 No other
hormone has a half-life this long and few hormones
are found in serum at these concentrations. These
elements are largely the result of tight noncovalent
binding to three principal serum T4-binding proteins,
Thyroxin-Binding Globulin (TBG), Transthyretin
(TTR) and albumin. The bound T4 is in rapid equilibrium with unbound or “free” T4 that is available
for cellular uptake. Because T4 is more avidly bound
to these proteins, it has a much longer half-life than
T3. Adult male rats do not appear to produce TBG,16
but pregnant females and pups produce high levels of
TBG.17-19 There are chemicals that are well known to
displace T4 from serum binding proteins (e.g., Polychlorinated Biphenyls (PCBs)20,21 and Polybrominated
Diphenyl Ethers (PBDEs).22-24
Chemicals that can displace TH from these binding proteins may cause a very rapid decline in serum
hormone levels. For example, salicylate can cause a
rapid (within 2 minutes) and dramatic reduction in
serum T4 that can be attributed to biliary clearance.25
This is also true for environmental chemicals such
as PCBs.26 Thus, it may well be the combination of
the ability of xenobiotics to displace TH from serum
binding proteins and their ability to induce phase
I-III enzymes. However, this scenario has not been
fully explored.
Recent observations from the Privalsky lab provide valuable information about the regulation of TH
action mediated by TRs. This group is identifying
somatic mutations of TRs that are associated with human cancers and studying the consequences of these
mutations on TR function.27 Their studies indicate
that structural changes associated with mutations in
the TR can alter transcriptional regulation and DNA
recognition.27 In addition, mutations in the TR can affect the transcriptional potency of T3 without affecting
the affinity of the TR for T3.28 These observations are
important because they establish a precedent and a
strategy for testing the hypothesis that xenobiotic TR
ligands might fit imprecisely into the ligand binding
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pocket of the TR – or into an allosteric site – to alter
the structure of the TR, causing it to function in ways
that are not a simple activation/inhibition but rather
a qualitative change, the consequence of which will
be difficult to predict.

www.epa.gov/endo/pubs/assayvalidation/status.htm).
However, this is true only for those thyroid toxicants
that affect serum TSH and it seems both unwise and
premature to assume that if TSH does not increase,
serum T4 does not decrease.

Role of TH in Development and in Adult
Physiology
Thyroid hormone is essential for normal brain development. This statement is supported by decades of
study both in experimental animals and in humans,29
though a detailed analysis of this literature is beyond
the scope of the current review. Nevertheless, there are
several issues that are important to highlight within
the framework of thyroid toxicology and these will
be developed here.

Compensation
Another critical issue is that of compensation.
This concept posits that as thyroid hormone (both
T4 and T3) levels decline, a number of systemic and
tissue-level responses are activated which abrogate
or ameliorate the consequences of low TH. This concept is extremely important for risk assessment, but
despite its implication, it appears to lack empirical
support. We also know that T4 metabolism and tissue
uptake may represent major elements of compensation, especially in the developing brain. We recently
addressed this issue directly but failed to identify
evidence for functional compensation to low thyroid
hormone in the developing rat brain.32 These findings
are consistent with a number of studies indicating that
very small changes in serum T4 can exert adverse effects on brain development.32 The above observations
indicate that we may not fully understand the degree
to which “compensation” occurs or the conditions
under which it occurs.

Idealized Model of the HPT Axis
in Development
A key issue to consider is that the dynamic interactions among hormones and tissues that make up
the HPT axis may be altered by exposure to various
xenobiotics in ways that are not fully understood.
For example, according to an idealized model of the
HPT axis, if a xenobiotic chemical causes a decrease
in circulating levels of T4, then serum TSH should
increase. However, there are a number of chemicals
that cause a decrease in serum total and free T4 without
causing a concomitant increase in serum TSH. One
of the best-known examples is that of PCBs. Exposure to the technical mixture Aroclor 1254 causes a
significant decrease in serum T4, but does not cause
an increase in serum TSH, while the thyroid gland
does not show signs of stimulation such as thyrocyte
proliferation.30,31
The mechanism by which a toxicant can cause a
decrease in the circulating level of T4 without affecting serum TSH is not clear. Moreover, it may differ
between toxicants that induce this effect. This is a
poorly studied area of research but is critical because
a large number of chemicals produce such effects.
Moreover, failure of the HPT axis to respond in an
idealized way makes identification of biomarkers with
adverse effects more complicated. For example, the
U.S. Environmental Protection Agency (EPA) proposes that the effect of chemical exposure on thyroid
histopathology is an important endpoint for a testing
program designed to identify thyroid toxicants (http://

Complexity of TRs
There are many factors that we need to understand about the receptors mediating TH action in
the developing brain. Clearly, there are studies that
support the hypothesis that different TR isoforms
mediate different actions of TH. 33-37 Moreover, the
different TR isoforms have different responses to
T327,28 as well as to different toxicants. 38 This is of
great interest because the consequences of thyroid
toxicants that interact with TRs in an isoform-specific
manner may well produce a mosaic of effects that do
not recapitulate the effects of global hypothyroidism
(or hyperthyroidism).39
Chemicals that Interfere
with the HPT Axis
There is a large number of chemicals that have been
shown to affect the HPT axis.40,41 However, all of these
chemicals have been identified as thyroid toxicants
because of their ability to reduce circulating levels
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of thyroid hormones. Although it is clear that this is
an important/key mechanism of thyroid toxicity, it is
not the only mechanism and an increasing number
of chemicals have been shown to interfere with the
TR directly or with enzymes or transporters that
play important roles in mediating TH action. These
issues are highlighted in the classes of chemicals
discussed below.
Polychlorinated Biphenyls (PCBs)
PCBs are a family of industrial compounds consisting of two linked phenyl rings and varying degrees of
chlorination, resulting in 209 different “congeners”.42,43
Before their production was banned in the 1970s,
over a billion kilograms of PCBs were produced44
and they are now persistent and ubiquitous environmental contaminants that are routinely found
in samples of human and animal tissues.42,45 PCBs
are developmental neurotoxins. Schantz and Rice46
reviewed this literature for humans prior to 2003 and
concluded that, on balance, there was strong evidence
indicating that PCB exposure is associated with negative effects on cognitive development. Interestingly,
many different neuropsychological strategies have
been used to identify effects of PCB exposure on
cognitive function, providing additional strength for
this conclusion. Several studies published since 2003
provide additional support for the conclusion that PCB
are neurotoxic. For example, Stewart et al47 reported
that cord blood PCBs were significant predictors of
deficits in McCarthy performance at 38 months of
age in children enrolled in the Oswego Newborn and
Infant Development Project. These relationships were
however not observed at 54 months, indicating that
functional compensation may occur. In a later study,
Stewart et al48 reported a significant negative association between prenatal PCB exposure (cord blood
PCBs) and both full scale and verbal IQ in children 9
years old. In addition, this group found that the size of
the corpus callosum on MRI images was a significant
predictor of the strength of the association between
PCB exposure and response inhibition49 in children
aged 4 years and that this effect was retained in these
children at age 9 years.50
Hertz-Picciotto et al51 identified a different kind
of potential effect of PCB exposure – the negative
association between measures of prenatal PCB ex-
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posure and thymus size in the infant. This observation is important both because there may be a link
between the neurodevelopmental effects of PCB
exposure and effects on immune development, but
also because of considerable potential consequences
of immune dysfunction. Finally, this group also identified a unique negative association between a specific
hydroxylated PCB metabolite (4-OH-PCB 107) and
Mental Developmental Index (MDI) in children at
16 months of age in eastern Slovakia.52
An active area of investigation has been on the
mechanism(s) by which PCBs may produce neurodevelopmental effects. One mechanism proposed
early was that PCBs could interfere with the thyroid
system.53 Studies of the relationship between PCB
body burden and thyroid hormone levels in human
populations have produced variable results. This issue
has been extensively reviewed previously54,55 and will
not be repeated here. However, there are several issues
that are important to highlight and update. An early
observation indicated that people highly contaminated with PCBs that occurred in rice oil (“Yusho”
disease) exhibited elevated T4 and T 3 with normal
levels of TSH when measured over a decade after
the accident.56 Thus, an industrial accident provides
evidence in humans that high levels of PCB exposure
are associated with measures of altered thyroid function. Nonetheless, the findings are not consistent with
work in animals, which nearly uniformly confirm that
PCB exposure causes a reduction in circulating levels
of thyroid hormone. An interesting and potentially
significant paradox was reported by Goldey et al,57
who found that exposure to the technical mixture
Aroclor 1254 caused a reduction in serum total and
free T4 but did not affect serum TSH. This issue was
further developed by Klaassen, 30 who showed that
not only is TSH not raised by A1254 but that the
thyroid gland did not exhibit histological features of
stimulation by TSH.
Salay and Garabrant58 recently reviewed the complexity of this issue and concluded that, among studies they deem strongest, there tends to be an inverse
relationship between serum T3 and T4, but not for free
T4 or TSH. There is a notable additional observation
recently reported. Specifically, birth delivery mode
(i.e., vaginal versus cesarean) modified the association between prenatal exposure to PCBs and neonatal
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thyroid hormone measures. 59 This is an important
observation indicating that a number of biological
sources of variation may exist that serve to obscure
vital relationships between toxicant exposure and
thyroid hormone levels.
Because PCB effects on circulating levels of TH
may not accurately reflect an effect on TH action
itself, we initially pursued the hypothesis that PCBs
interfere with TH action in the developing rodent
brain producing a state of relative hypothyroidism.
Surprisingly, we found that A1254 reduced circulating levels of T4 to below the detection limit for the
radioimmunoassay, yet the TH -responsive genes
RC3/Neurogranin and Myelin Basic Protein (MBP)
were up-regulated as if T4 levels were increased.60 To
pursue this hypothesis, we developed a mixture of
6 PCB congeners.119 In pregnant rats, this mixture
reproduced the effect of A1254 in that it significantly
decreased serum T4 levels but increased the expression
of a TH-responsive gene (malic enzyme). Moreover,
we showed that this mixture could enhance transcription through a specific TH response element (a DR4),
which minimally required the combination of PCBs
105, 118, and 126. Finally, using pharmacological
approaches, we showed that the ability of PCBs to
increase TR activity required CYP1A1, indicating
that parent PCBs must be hydroxylated to form TR
agonists. Interestingly, the PCB metabolite predicted
to be formed by CYP1A1 activity is 4-OH-PCB107,
which was uniquely associated with Mental Development Index (MDI) by Park et al.120
Polybrominated Diphenyl Ethers (PBDEs)
Polybrominated diphenyl ethers are primarily
employed as flame retardants in consumer products
to delay ignition and burning of materials. Because
they are added to the materials rather than chemically bound, they can leach from the materials into
the environment over time and use.62 Because of
their lipophilicity, PBDEs bioaccumulate and levels
of PBDEs in human tissues have exhibited significant
increases over the past decade,63 including serum,64
milk65-69 and cord blood. 59,62 Interestingly, PBDE
body burden of North Americans is the highest in
the world70 with toddlers being exposed to nearly 10
times as much as adults.69 Thus, it is clear that PBDEs
have made their way into the human population, that
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PBDE levels are rising, this indicating continual exposures, and that PBDEs have gained access to human
development during fetal71 and neonatal life.
Because of the ability of PBDEs to bioaccumulate
and because blood levels are increasing, especially
in children, it is essential to evaluate their endocrine
toxicity. Moreover, their structure – with two halogenated phenyl rings attached by an ether link – is
considerably more similar to thyroid hormone than
are other known thyroid disruptors like PCBs. Hence,
a number of studies have recently evaluated the ability
of PBDEs to disrupt thyroid function both in animals
and in humans. In rodents, PBDE exposure has been
repeatedly found to decrease serum total and free T4
and increase serum TSH.72-77 These observations are
dependent to some extent upon the specific PBDE
mixture employed in the study, with the lower brominated compounds appearing more potent in reducing
serum thyroid hormone levels. Stoker et al75 and Szabo
et al72 investigated some of the potential mechanisms
by which PBDE exposure may lead to a reduction in
circulating levels of thyroid hormone. These studies
show that a combination of changes in serum T4 binding, T4 conjugation and elimination, and changes in
T4 metabolism by deiodination may all be involved
in the pathway by which PBDE exposure may reduce
circulating levels of thyroid hormone.
Fewer studies have evaluated the relationship between PBDE exposure and thyroid status in humans.
Early work did not reveal a relationship between
PBDE body burden and thyroid hormone levels in
human serum.71,78 These two small studies focused on
mother-infant pairs in central Indiana (USA)71 and
occupational exposure in an electrical recycling plant
in Sweden.78 More recently, Herbstman et al59 reported
on a larger study of mother-infant pairs. This study
was enhanced by their background work indicating
that delivery mode affects thyroid hormone levels in
the infant.79 Thus, using this information, they then
found that PBDE levels in cord blood at birth were
negatively associated with both total and free T4 in
those babies born by vaginal delivery. In contrast, the
stress associated with conditions leading to a cesarean
delivery apparently were such that they masked this
relationship. This observation is critical first because
it indicates that PBDE body burden may produce a
stressor on the thyroid system during development and

Environmental chemicals targeting thyroid

second because it indicates that our ability to identify
these relationships is dependent upon eliminating
variables that can mask this relationship.
Interestingly, several animal studies revealed that
PBDE exposure could lower circulating levels of
vitamin A.77,80 This is noteworthy because retinoic
acid signaling is a potentially important co-regulator
of gene expression with thyroid hormone signaling.81
It is therefore essential to ascertain whether PBDE
exposure can potentially reduce the circulating levels
of both thyroid hormone and vitamin A. Moreover, the
condition of marginal vitamin A deficiency renders
rodents significantly more sensitive to the TH-lowering effect of PBDEs.82 These novel studies indicate
that PBDE exposure may exert independent effects
on circulating levels of thyroid hormone and vitamin
A, but that the cross-talk between these two signaling
systems may be a target of PBDE action.
Limited data also indicate that some PBDEs, or
their hydroxylated metabolites, can interact directly
with thyroid hormone receptors. Marsh et al83 reported
that 4’-hydroxy-1,3,3’,5-tetrabromodiphenyl ether
could bind to the beta isoform of the TR (TRβ1) with
an affinity about 150-fold lower than that of T3. In
addition, this hydroxylated PBDE exhibited a 40-fold
lower affinity for TRα1 than for TRβ1. Kojiba et al84
have evaluated the ability of a different set of PBDEs
and their metabolites to affect the thyroid hormone
receptor. In this case, they evaluated the ability of
these compounds to affect TR function in transcription assays using CHO-K1 cells and a palindromic
TH response element. They found that 4-OH-BDE90
exerted a significant antagonistic effect on TRα1 and
TRβ1 at 10 -5M. There were no apparent differences
between the effects on TRα1 or TRβ1.
Taken together, these studies indicate that PBDEs
are thyroid toxicants that clearly reduce measures of
thyroid function in the animal system and for which
there is credible evidence for an effect in humans.
Moreover, specific PBDE congeners and/or metabolites may affect thyroid hormone binding to its
receptor or receptor function directly.
Perchlorate
Perchlorate is a powerful oxidant used as a rocket
propellant, in ordinance, fireworks, airbag deployment
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systems, and others.85 Because of the environmental
stability and prevalence of use of perchlorate, it has
become a widespread contaminant in drinking and
irrigation waters and in food,86 such that perchlorate
contamination is nearly ubiquitous in the US population.87 Experimental studies in humans indicate that
the serum half-life of perchlorate is about 8 hours
and that an exposure level of about 5.2 µg/kg/day is
sufficient to begin to reduce iodide uptake into the
thyroid gland.88 Because the adult thyroid gland stores
a great deal of hormone in the form of iodinated thyroglobulin, it was surprising that Blount et al89 found
that urinary perchlorate levels were associated with
serum TSH in the general population of women (not
in men). It is perhaps not surprising that this association was greater in women with urinary iodine below
100 µg/L, and stronger still among these women who
smoke,90 since cigarettes contain thiocyanates that also
inhibit iodine uptake. Because infants are particularly
vulnerable to thyroid hormone insufficiency29 and
because perchlorate levels are particularly high in
breast milk,91 it is of concern that perchlorate may be
affecting TH signaling in early infant development
in some proportion of the US population.92
Predicting the consequences of environmental
perchlorate exposure on thyroid function and thyroid hormone action reveals several serious weaknesses in our understanding of the thyroid system
as we employ this information for risk assessment.
Perhaps most importantly, it remains enigmatic that
the high-dose short-term human exposure studies of
Greer et al88 and Lawrence et al93,94 failed to predict
the association of low-dose long-term perchlorate
exposure reported by Blount et al89 and Steinmaus
et al.90 The mechanism of perchlorate action on the
thyroid system is relatively simple and is believed to
be mediated solely by inhibiting iodide uptake into the
thyroid gland.95,96 As a result, perchlorate is expected
to interfere with thyroid function by reducing iodide
uptake and, ultimately, thyroid hormone synthesis.
Thus, perhaps the single most important lesson to
be learned from the study of perchlorate is why early
studies did not allow us to identify potential adverse
effects of low-dose chronic exposures.
Bisphenol-A
Bisphenol-A (BPA, 4,40-isopropylidenediphenol)
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is one of the highest volume chemicals produced
worldwide. Over 6 billion pounds are produced each
year and over 100 tons are released into the atmosphere by yearly production.104 This chemical is the
primary building block of polycarbonate plastic,
but is also found in a large number of consumer
products, epoxy resins that coat food cans, and in
dental sealants.105,106 Howe et al106 estimated human
consumption of BPA from epoxy-lined food cans
alone to be about 6.6 mg/person/day. Several recent
reviews have comprehensively discussed the known
sources and human exposures to BPA107-110 and will
not be further explored here. However, it is important to note that BPA is found in serum of pregnant
women, in the amniotic fluid of their fetus, in placenta,
and in cord serum taken at birth.111,112 Finally, it is
of considerable interest to highlight a recent study
that found a longer than expected retention time for
BPA in humans with substantial non-food sources of
exposure.108 It is thus clear that the human population
is ubiquitously exposed to BPA through sources that
are incompletely understood.
BPA is also halogenated (brominated or chlorinated) to produce flame retardants. Tetrabromobisphenol-A (TBBPA) is the most commonly used, with
over 60,000 tons produced annually.113,114 Thomsen
et al115 have recently reported that brominated flame
retardants, including TBBPA, increased in human
serum from 1977 to 1999 with concentrations in
adults ranging from 0.4 to 3.3 ng/g serum lipids, while
infants (0-4 years) exhibited serum concentrations
that ranged from 1.6 to 3.5 times higher.
Of potential significance is the fact that BPA
was shown to bind to the TR acting as an antagonist on gene expression.116 Best characterized as
a weak estrogen binding to the estrogen receptor
with a Ki of approximately 10 -5M,117,118 BPA binds to
and antagonizes T3 activation of the TR with a Ki
of approximately 10 -4M, but as little as 10 -6M BPA
significantly inhibits TR-mediated gene activation.
Moreover, Moriyama et al116 found that BPA reduced
T3-mediated gene expression in culture by enhancing
the interaction of the TR with the corepressor N-CoR.
Interestingly, Kitamura reported that tetrachloro- and
tetrabromobisphenol-A can bind to the TR with a
higher affinity than does parent BPA, and that they
act as an agonist on the TR when the rat pituitary
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cell line GH3 growth is used as an index of thyroid
hormone action.119 These early studies indicated that
BPA could exert a direct action on thyroid hormone
signaling through the TR, which complicates our
ability to predict the outcome of BPA exposure on
thyroid hormone-regulated developmental or physiological endpoints.
These issues have become further complicated by
recent in vitro studies showing that BPA is an antithyroid agent in the absence of a canonical Thyroid
Response Element (TRE). In general, BPA is identified as an antagonist and the halogenated forms as an
agonist, but this is not uniformly observed. Although
the active dose of these compounds typically is reported to be in the micromolar range, some effects
were reported in the sub-nanomolar range.
Considering these findings in vitro, it is not surprising that actions of BPA on thyroid hormone
signaling have also been reported in in vivo assays.
Iwamuro129 first reported that BPA could block thyroid
hormone-induced tail resorption during Xenopus
metamorphosis. This report was followed by a study
using primary mouse Oligodendrocyte Precursor
Cells (OPCs) finding that 10 -5M BPA could inhibit
T3-induced specification of oligodendrocytes.130 Our
lab then found that developmental exposure to BPA
in rats produces an endocrine profile similar to that
observed in thyroid resistance syndrome.131 Specifically, T4 levels were elevated during development in
the pups of BPA-treated animals, but TSH levels were
not different from controls. This profile is consistent
with BPA inhibition of TRβ-mediated negative feedback. By contrast, the TH-response gene RC3 was
elevated in the dentate gyrus of these BPA-treated
animals.131 Because the TRα isoform is expressed in
the dentate gyrus, we concluded that BPA may be a
selective TRβ antagonist in vivo. These observations
were partly confirmed by Xu et al,132 who reported that
BPA exposure increased serum free T4 in dams and in
pups prior to P21. However, they did not observe RC3
expression alteration in the hippocampus. Given that
SRC-1 appears to be up-regulated by thyroid hormone
in these regions of the hippocampus,133 the findings
of Xu et al may indicate either that the BPA-induced
increase in free T4 is responsible for increasing SRC-1
expression or that BPA is having this effect directly.
Because of the consistent finding that BPA is a TR
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agonist, it seems likely that the former interpretation
has the greatest support.
If BPA is a selective TRβ antagonist in vivo, it is
possible that it could produce effects similar to thyroid resistance syndrome in which the TRβ receptor
is defective leading to elevated serum T4 and either
normal or slightly elevated TSH.134 In this regard,
it is potentially important to note that there may
be an association between thyroid resistance and
attention-deficit hyperactivity disorder (ADHD) in
humans101,135,136 and in rats.137 Therefore, it is possibly
significant that BPA-exposed rats exhibit ADHD-like
symptoms.138 In addition, BPA exposure alters neocortical histogenesis in the mouse.139,140 Although no
specific link was made to TH action in this study, the
findings are consistent with the hypothesis that BPA
alters early development of the cortex by interfering
with TH signaling.
These experimental studies provide strong evidence that BPA can interfere with TH signaling both
in vitro and in vivo. However, because of the complex
nature of the interaction of BPA (and halogenated
derivatives) with the TH receptor, it is likely to be
difficult to identify thyroid disrupting effects of BPA
in humans. Despite this, Sugiura-Ogasawara et al141
found that BPA exposure was associated with recurrent miscarriage, and early fetal loss associated
with both elevated142 and reduced143 serum T4. Thus,
considering the widespread exposure of the human
population to BPA, it will be of considerable interest
to explore the potential relationship between BPA
exposure and thyroid disruption.
Summary and Conclusions
Animal studies are revealing both the complexity
of the thyroid system and the complexity of the ways
in which EDCs may interfere with TH signaling. A
significant conclusion that needs to be drawn from
these studies is that the current clinical strategy of
evaluating thyroid disease (i.e. measure blood levels
of hormones, antibodies and proteins) is not sufficient
to identify EDC actions on thyroid hormone signaling that may well be associated with disease in the
human population. Moreover – and less defensible
– screening and testing strategies to identify thyroid
toxicants focus on an extremely limited number of

35

endpoints.144 Clearly recent studies of EDC actions
on the thyroid system need to be taken into account
in both clinical and regulatory studies.
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